Tag: #Robertford

Abbott CEO claims the FreeStyle Libre continuous glucose monitoring platform as the most successful medtech product in history, targeting a $10 billion sales goal by 2028. Discover the innovative strategies driving Abbott’s growth and expansion into consumer health wearables beyond diabetes.